Diagnostic Reagents And Vaccines For Multiple Genotypes Of Hepatitis C Virus

The invention describes the complete nucleotide and deduced amino acid sequences of the envelope 1 (E1) gene of 51 hepatitis C virus (HCV) isolates from around the world and the grouping of these isolates into twelve distinct HCV genotypes. More specifically, this invention relates to the oligonucleotides, peptides and recombinant proteins derived from the envelope 1 gene sequences of these isolates and to diagnostic methods and vaccines that employ these reagents.IC: NIAIDNIH Ref. No.: E-120-1993-0TAB No: TAB-136Provider Technology ID: 136Updated On: Jul 6, 2020Date Published: Monday, July 6, 2020Patent Application: PCT/US94/0732008/086,42808/468,57008/466,601Patent Authority: PCTUSUSUSEIRPatent Number: 5,514,5395,871,9626,572,864Lead Inventor: Inventor IC: NIAIDNIAIDLPM FIrst Name: PeterLPM Last Name: SoukasLPM Address: 5601 Fishers Lane, Suite 6D (MSC 9804)LPM City: RockvilleLPM Zip: 20892-9804Inv Is lead: LPM State: MDLPM Phone: [phone]LPM Email: [e-mail] Suffix: J.D.LPM Organization: NIH Office of Technology TransferLPM Fax: [phone]DTDT Classification: Infectious DiseasesTherapeuticsAnti-viralsResearch MaterialsDTDT Description: Infectious DiseasesInfectious Diseases - TherapeuticsInfectious Diseases - Therapeutics - Anti-viralsInfectious Diseases - Research MaterialsPat Filing Date: 1994-06-281993-06-291995-06-061995-...

Source: NIH OTT Licensing Opportunities - July 6, 2020 Category: Research Authors: ott-admin Source Type: research